Abiraterone
Back to search| Scientific Name: | Abiraterone |
| Brand Name: | Yonsa, Zytiga |
| Company Owner: | Not Available |
| Mechanism Of Action | Abiraterone is an orally active inhibitor of the steroidal enzyme CYP17A1 (17 alpha-hydroxylase/C17, 20 lyase) . It inhibits CYP17A1 in a selective and irreversible manner via covalent binding mechanism. CYP17A1 is an enzyme that catalyzes the biosynthesis of androgen and is highly expressed in testicular, adrenal, and prostatic tumor tissue. More specifically, abiraterone inhibits the conversion of 17-hydroxyprognenolone to dehydroepiandrosterone (DHEA) by the enzyme CYP17A1 to decrease serum levels of testosterone and other androgens. |
| Description of the Drug: | Abiraterone is an antiandrogen used in the treatment of prostate cancer. |
| Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB05812
